IBDEI0JC ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19489,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,19489,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,19489,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,19490,0)
 ;;=E11.39^^86^986^18
 ;;^UTILITY(U,$J,358.3,19490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19490,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,19490,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,19490,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,19491,0)
 ;;=E11.43^^86^986^15
 ;;^UTILITY(U,$J,358.3,19491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19491,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,19491,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,19491,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,19492,0)
 ;;=E11.59^^86^986^13
 ;;^UTILITY(U,$J,358.3,19492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19492,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,19492,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,19492,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,19493,0)
 ;;=E11.618^^86^986^14
 ;;^UTILITY(U,$J,358.3,19493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19493,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,19493,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,19493,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,19494,0)
 ;;=E11.621^^86^986^16
 ;;^UTILITY(U,$J,358.3,19494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19494,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,19494,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,19494,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,19495,0)
 ;;=E11.622^^86^986^20
 ;;^UTILITY(U,$J,358.3,19495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19495,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,19495,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,19495,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,19496,0)
 ;;=E11.65^^86^986^19
 ;;^UTILITY(U,$J,358.3,19496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19496,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,19496,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,19496,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,19497,0)
 ;;=E11.9^^86^986^21
 ;;^UTILITY(U,$J,358.3,19497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19497,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,19497,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,19497,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,19498,0)
 ;;=E13.9^^86^986^22
 ;;^UTILITY(U,$J,358.3,19498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19498,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,19498,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,19498,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,19499,0)
 ;;=E16.2^^86^986^29
 ;;^UTILITY(U,$J,358.3,19499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19499,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,19499,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,19499,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,19500,0)
 ;;=E20.0^^86^986^34
 ;;^UTILITY(U,$J,358.3,19500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19500,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,19500,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,19500,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,19501,0)
 ;;=E20.9^^86^986^30
 ;;^UTILITY(U,$J,358.3,19501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19501,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,19501,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,19501,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,19502,0)
 ;;=E23.0^^86^986^31
 ;;^UTILITY(U,$J,358.3,19502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19502,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,19502,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,19502,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,19503,0)
 ;;=E27.1^^86^986^51
 ;;^UTILITY(U,$J,358.3,19503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19503,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,19503,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,19503,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,19504,0)
 ;;=E27.2^^86^986^1
 ;;^UTILITY(U,$J,358.3,19504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19504,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,19504,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,19504,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,19505,0)
 ;;=E27.3^^86^986^23
 ;;^UTILITY(U,$J,358.3,19505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19505,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,19505,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,19505,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,19506,0)
 ;;=E29.1^^86^986^52
 ;;^UTILITY(U,$J,358.3,19506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19506,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,19506,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,19506,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,19507,0)
 ;;=E55.9^^86^986^59
 ;;^UTILITY(U,$J,358.3,19507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19507,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,19507,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,19507,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,19508,0)
 ;;=E66.01^^86^986^38
 ;;^UTILITY(U,$J,358.3,19508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19508,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,19508,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,19508,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,19509,0)
 ;;=E66.8^^86^986^42
 ;;^UTILITY(U,$J,358.3,19509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19509,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,19509,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,19509,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,19510,0)
 ;;=E66.9^^86^986^43
 ;;^UTILITY(U,$J,358.3,19510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19510,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,19510,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,19510,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,19511,0)
 ;;=E74.39^^86^986^35
 ;;^UTILITY(U,$J,358.3,19511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19511,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,19511,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,19511,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,19512,0)
 ;;=E83.30^^86^986^46
 ;;^UTILITY(U,$J,358.3,19512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19512,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,19512,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,19512,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,19513,0)
 ;;=E83.51^^86^986^28
 ;;^UTILITY(U,$J,358.3,19513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19513,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,19513,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,19513,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,19514,0)
 ;;=E83.52^^86^986^26
 ;;^UTILITY(U,$J,358.3,19514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19514,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,19514,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,19514,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,19515,0)
 ;;=E87.5^^86^986^27
 ;;^UTILITY(U,$J,358.3,19515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19515,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,19515,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,19515,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,19516,0)
 ;;=E89.2^^86^986^48
 ;;^UTILITY(U,$J,358.3,19516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19516,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,19516,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,19516,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,19517,0)
 ;;=E89.6^^86^986^47
 ;;^UTILITY(U,$J,358.3,19517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19517,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,19517,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,19517,2)
 ;;=^5003042
